These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22426510)

  • 1. Targeting imidazoline site on monoamine oxidase B through molecular docking simulations.
    Moraes FP; de Azevedo WF
    J Mol Model; 2012 Aug; 18(8):3877-86. PubMed ID: 22426510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational comparison of imidazoline association with the I2 binding site in human monoamine oxidases.
    Basile L; Pappalardo M; Guccione S; Milardi D; Ramsay RR
    J Chem Inf Model; 2014 Apr; 54(4):1200-7. PubMed ID: 24601544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
    Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
    Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors.
    Mellado M; González C; Mella J; Aguilar LF; Viña D; Uriarte E; Cuellar M; Matos MJ
    Bioorg Chem; 2021 Mar; 108():104689. PubMed ID: 33571810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
    Tripathi RK; Goshain O; Ayyannan SR
    ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking of inhibitors into monoamine oxidase B.
    Harkcom WT; Bevan DR
    Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular aspects of monoamine oxidase B.
    Ramsay RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():81-9. PubMed ID: 26891670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    McDonald GR; Olivieri A; Ramsay RR; Holt A
    Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
    Raddatz R; Parini A; Lanier SM
    J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.
    Yelekçi K; Karahan O; Toprakçi M
    J Neural Transm (Vienna); 2007; 114(6):725-32. PubMed ID: 17401533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
    Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
    Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties.
    Is YS; Durdagi S; Aksoydan B; Yurtsever M
    ACS Chem Neurosci; 2018 Jul; 9(7):1768-1782. PubMed ID: 29671581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
    Lee HW; Ryu HW; Kang MG; Park D; Oh SR; Kim H
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1136-1140. PubMed ID: 28188065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach.
    Mubashir N; Fatima R; Naeem S
    Curr Comput Aided Drug Des; 2020; 16(4):420-434. PubMed ID: 32883197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
    Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H
    Molecules; 2021 May; 26(11):. PubMed ID: 34071665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steered molecular dynamics simulations reveal important mechanisms in reversible monoamine oxidase B inhibition.
    Allen WJ; Bevan DR
    Biochemistry; 2011 Jul; 50(29):6441-54. PubMed ID: 21682347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.